首页> 美国卫生研究院文献>Journal of Hematology Oncology >Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
【2h】

Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer

机译:单细胞RNA测序揭示胰腺癌中抗CD47靶向诱导的肿瘤浸润免疫细胞的区室重塑

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunostaining of CD47, PD-L1, CD68, and CD163 in human PDAC. Staining with an anti-CD47, anti-PD-L1, anti-CD68, and anti-CD163 antibody in the human PDAC tissue samples at × 100 magnification and × 400 magnification. Scale bar = 50 μm (red line at the bottom left). Results of immunohistochemical staining. Immunoblotting of CD47 and PD-L1 in PDAC cell lines. ACTB (β-actin) was used as a normalization control. Kaplan–Meyer plot of OS in 106 PDAC patients with high or low tumor CD47 expression. Kaplan–Meyer plot of OS in 106 PDAC patients with high or low tumor PD-L1 expression. , Kaplan–Meyer plot of OS in 106 PDAC patients with high or low tumor-infiltrating CD68 ( ) or CD163 macrophages ( ). – Kaplan–Meyer plot of OS among four groups of patients divided on the combinations of two variables with high and low expression. is an illustration of – . The four groups are and in blue, and in gold, and in green, and and in red. “ ” and “ ” represent the two different variables (CD47, PD-L1, CD68 M, or CD163 M2). “ ” represent the numbers of patients in four groups (blue, gold, green, and red)
机译:人PDAC中CD47,PD-L1,CD68和CD163的免疫染色。在人PDAC组织样本中以抗CD47,抗PD-L1,抗CD68和抗CD163抗体进行染色,放大倍数为100倍,放大倍数为400倍。比例尺=50μm(红线在左下角)。免疫组织化学染色的结果。 PDAC细胞系中CD47和PD-L1的免疫印迹。 ACTB(β-肌动蛋白)被用作标准化对照。 106例高或低肿瘤CD47表达的PDAC患者的OS Kaplan-Meyer图。 106例高或低肿瘤PD-L1表达的PDAC患者的OS Kaplan-Meyer图。 ,Kaplan–Meyer图在106例高或低肿瘤浸润CD68()或CD163巨噬细胞()的PDAC患者中的OS。 –在四组患者中的OS的Kaplan–Meyer绘图根据高表达和低表达两个变量的组合进行划分。是–的例证。这四个组分别是和,分别为蓝色,金色,绿色,红色。 “”和“”代表两个不同的变量(CD47,PD-L1,CD68 M或CD163 M2)。 “”代表四组患者的数量(蓝色,金色,绿色和红色)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号